GlassScriptPhysician profile
Sanjay B Pandya
NPI 1639277353
$62,369.40
in general payments reported to CMS, 2019-2025
22 companies · $16K in 2025
The $16K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,248 · 2020: $399 · 2021: $1,972 · 2022: $3,509 · 2023: $9,211 · 2024: $29K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Consulting Fee: $15K · Honoraria: $9,000 · Travel and Lodging: $6,730 · Food and Beverage: $6,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,000.00 |
| Consulting Fee | $15,000.00 |
| Honoraria | $9,000.00 |
| Travel and Lodging | $6,729.86 |
| Food and Beverage | $6,511.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $40,076.44 | 2019-2025 | General - Balloons, Avvigo Guidance System, General - Vascular Access |
| Abiomed | $10,888.78 | 2019-2025 | Impella |
| Medtronic, INC. | $6,990.91 | 2022-2025 | Corevalve Evolut R, Closurefast |
| Edwards Lifesciences Corporation | $2,036.24 | 2021-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medical Device Business Services, INC. | $978.53 | 2019 | |
| Abbott Laboratories | $356.39 | 2019-2025 | Triclip, Mitraclip, 2nd Gen Centrimag Primary Console |
| Actelion Pharmaceuticals US, INC. | $194.75 | 2019 | |
| Shockwave Medical, INC | $145.31 | 2025 | |
| Cvrx, INC. | $125.96 | 2023 | Barostim Neo System |
| Acist Medical Systems, INC. | $110.47 | 2022-2024 | |
| Inari Medical, INC. | $104.61 | 2019-2022 | |
| Celonova Biosciences, INC. | $104.31 | 2020 | |
| Janssen Pharmaceuticals, INC | $58.60 | 2020-2021 | |
| Endovascular Engineering INC. | $33.63 | 2024-2025 | Helo Thrombectomy System |
| Cardiva Medical, INC. | $29.23 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $27.20 | 2025 | Indigo System |
| Angiodynamics, INC. | $24.57 | 2019 | |
| Biotronik INC. | $23.14 | 2022 | |
| Cordis US Corp. | $20.75 | 2025 | Mynx Control |
| Tactile Systems Technology INC | $20.51 | 2019 | |
| Philips North America LLC | $19.07 | 2024 | (Br5) Peripheral Ivus |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Pandya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.